10-K is out. They flatly state: "In Septermber 201
Post# of 1460
Posted On: 12/14/2016 4:33:54 PM
10-K is out. They flatly state: "In Septermber 2016, the Company presented positive preclinical data for ANAVEX 2-73 in Parkinson's disease, which demonstrated significant improvements on all measures: behavioral, histopathological, and neuroinflammatory endpoints."
They also talk about how they intend to try to partner up.
They also talk about how they intend to try to partner up.
(1)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼